HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 257 filers reported holding HAEMONETICS CORP in Q2 2019. The put-call ratio across all filers is 2.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $21,909,000 | -22.2% | 250,445 | -11.0% | 0.03% | -32.5% |
| Q4 2018 | $28,146,000 | +7.9% | 281,322 | +23.5% | 0.04% | +33.3% |
| Q3 2018 | $26,096,000 | +32.9% | 227,748 | +4.0% | 0.03% | +30.4% |
| Q2 2018 | $19,640,000 | +35.7% | 218,990 | +10.7% | 0.02% | +27.8% |
| Q1 2018 | $14,475,000 | +2022.4% | 197,852 | +1584.7% | 0.02% | +1700.0% |
| Q4 2017 | $682,000 | +2.9% | 11,744 | -20.4% | 0.00% | 0.0% |
| Q3 2017 | $663,000 | -1.6% | 14,761 | -13.5% | 0.00% | 0.0% |
| Q2 2017 | $674,000 | -7.9% | 17,071 | -5.4% | 0.00% | 0.0% |
| Q1 2017 | $732,000 | +29.1% | 18,047 | +27.9% | 0.00% | 0.0% |
| Q4 2016 | $567,000 | +34.4% | 14,113 | +21.1% | 0.00% | 0.0% |
| Q3 2016 | $422,000 | -1.4% | 11,652 | -21.1% | 0.00% | 0.0% |
| Q2 2016 | $428,000 | +7.0% | 14,774 | +29.2% | 0.00% | 0.0% |
| Q1 2016 | $400,000 | -17.9% | 11,433 | -24.3% | 0.00% | – |
| Q4 2015 | $487,000 | – | 15,104 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bridge City Capital, LLC | 40,541 | $5,114,000 | 2.20% |
| Lisanti Capital Growth, LLC | 53,385 | $6,734,000 | 2.20% |
| Nitorum Capital, L.P. | 279,510 | $35,257,000 | 2.05% |
| CROWN ADVISORS MANAGEMENT, INC. | 20,000 | $2,523,000 | 1.69% |
| Millrace Asset Group, Inc. | 11,400 | $1,438,000 | 1.69% |
| COOKSON PEIRCE & CO INC | 145,884 | $18,402,000 | 1.61% |
| Endurant Capital Management LP | 32,594 | $4,111,000 | 1.48% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 111,000 | $14,002,000 | 1.38% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 110,065 | $13,884,000 | 1.37% |
| EMERALD ADVISERS, LLC | 203,640 | $25,687,000 | 1.20% |